Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Guidance on choosing your first blockchain to learn, comparing BTC and ETH basics and outlining a practical learning path.
25,072 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As natural gas swings capture traders’ attention, UNG and FCG offer competing paths: near-term futures exposure vs. e...
As macro conditions shift toward potential rate cuts and a steeper yield curve, the equal-weight strategy could outru...
Retirees are tilting funds toward a select group of Dividend Kings with multi-decade dividend raises and yields well ...
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...
Before you lend or invest, you need a clear view of the market. This guide covers four practical metrics to analyze a...
When a mining stock dropped today, investors often wonder what behind-the-scenes factors pushed the move. This guide ...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...
When pop culture and personal finance collide, even a Vegas celebration becomes a lesson in budgeting, sponsorships, ...
Jamie Dimon warns of parallels to the pre-financial crisis era as asset prices and volumes stay elevated. The JPMorga...
Calumet (CLMT) has been a variable name in energy markets. This guide breaks down calumet (clmt) 2025 earnings, what ...